` PYC (Physiomics PLC) vs FTSE All Share Index Comparison - Alpha Spread

PYC
vs
F
FTSE All Share Index

Over the past 12 months, PYC has outperformed FTSE All Share Index, delivering a return of +2% compared to FTSE All Share Index's 0% growth.

Stocks Performance
PYC vs FTSE All Share Index

Loading...
PYC
FTSE All Share Index
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
PYC vs FTSE All Share Index

Performance Gap Between PYC and ASX
LOCKED
Unlock

Performance By Year
PYC vs FTSE All Share Index

Loading...
PYC
FTSE All Share Index
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Physiomics PLC vs Peers

FTSE All Share Index
PYC
TMO
DHR
603259
LONN
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Physiomics PLC
Glance View

Physiomics Plc engages in the provision of outsourced systems and computational biology services to biopharmaceutical companies. The company is headquartered in Oxford, Oxfordshire and currently employs 10 full-time employees. The company went IPO on 2004-12-20. The firm offer its services by utilizing its proprietary Virtual Tumour predictive software, industry standard tools (such as NONMEM and MATLAB), as well as developing bespoke models using the R programming language. Virtual Tumour is a predictive quantitative systems' pharmacology (QSP) model used worldwide by global pharmaceuticals to small biotech companies to support oncology Research and development (R&D). The company is a semi-mechanistic model that incorporates an abstracted representation of the cell cycle, Deoxyribonucleic acid (DNA) damage/ repair and elements of the immune response. The firm is also developing its technology for use in the field of personalized medicine. The firm is focused on helping pharma and biotech clients.

PYC Intrinsic Value
LOCKED
Unlock
Back to Top